Patents by Inventor Nuri Park

Nuri Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9555091
    Abstract: The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein; (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence; (c) a nucleotide sequence encoding an antigen protein; and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence; and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen (e.g., HPV L1), enabling to function as a more efficient DNA vaccine.
    Type: Grant
    Filed: July 30, 2014
    Date of Patent: January 31, 2017
    Assignees: KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP., KR BIOTECH CO., LTD.
    Inventors: Young-Bong Kim, Hee Jung Lee, Nuri Park, Yu-Kyoung Oh
  • Publication number: 20150030621
    Abstract: The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein; (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence; (c) a nucleotide sequence encoding an antigen protein; and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence; and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen (e.g., HPV L1), enabling to function as a more efficient DNA vaccine.
    Type: Application
    Filed: July 30, 2014
    Publication date: January 29, 2015
    Inventors: Young-Bong KIM, Hee Jung Lee, Nuri Park, Yu-Kyoung Oh
  • Publication number: 20100285056
    Abstract: The present invention relates to a recombinant baculovirus comprising: (a) a nucleotide sequence encoding a foreign virus envelope protein; (b) a first promoter operatively linked to the envelope-encoding nucleotide sequence; (c) a nucleotide sequence encoding an antigen protein; and (d) a second promoter operatively linked to the antigen-encoding nucleotide sequence; and a vaccine composition using the same. The recombinant baculovirus of the present invention has an excellent efficacy on both humoral and cellular immune responses against a specific antigen (e.g., HPV L1), enabling to function as a more efficient DNA vaccine.
    Type: Application
    Filed: January 9, 2009
    Publication date: November 11, 2010
    Applicants: Konkuk University Industrial Cooperation Corp., KR Biotech Co., Ltd.
    Inventors: Young-Bong Kim, Hee Jung Lee, Nuri Park, Yu-Kyoung Oh